Agilent Technologies, Inc. $A Shares Sold by Elo Mutual Pension Insurance Co

Elo Mutual Pension Insurance Co decreased its position in Agilent Technologies, Inc. (NYSE:A) by 12.7% during the 2nd quarter, Holdings Channel reports. The fund owned 33,139 shares of the medical research company’s stock after selling 4,806 shares during the quarter. Elo Mutual Pension Insurance Co’s holdings in Agilent Technologies were worth $3,911,000 as of its most recent filing with the Securities & Exchange Commission.

Other large investors have also modified their holdings of the company. Vanguard Group Inc. raised its position in Agilent Technologies by 1.8% in the second quarter. Vanguard Group Inc. now owns 33,997,845 shares of the medical research company’s stock worth $4,012,086,000 after acquiring an additional 589,219 shares in the last quarter. Massachusetts Financial Services Co. MA increased its stake in Agilent Technologies by 10.7% in the 2nd quarter. Massachusetts Financial Services Co. MA now owns 13,227,387 shares of the medical research company’s stock valued at $1,560,964,000 after purchasing an additional 1,273,994 shares in the last quarter. Geode Capital Management LLC boosted its position in Agilent Technologies by 1.6% during the second quarter. Geode Capital Management LLC now owns 7,319,530 shares of the medical research company’s stock worth $860,137,000 after purchasing an additional 115,183 shares in the last quarter. Generation Investment Management LLP raised its stake in shares of Agilent Technologies by 15.9% during the 2nd quarter. Generation Investment Management LLP now owns 5,775,860 shares of the medical research company’s stock worth $681,609,000 after buying an additional 792,304 shares during the last quarter. Finally, UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC increased its holdings in Agilent Technologies by 18.7% during the 1st quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 3,836,105 shares of the medical research company’s stock valued at $448,748,000 after acquiring an additional 604,124 shares in the last quarter. 87.41% of the stock is owned by hedge funds and other institutional investors.

Analysts Set New Price Targets

A number of equities research analysts recently issued reports on A shares. Rothschild Redb raised Agilent Technologies to a “strong-buy” rating in a research note on Wednesday, October 8th. Barclays raised their target price on shares of Agilent Technologies from $145.00 to $165.00 and gave the stock an “equal weight” rating in a research report on Tuesday. UBS Group lifted their target price on shares of Agilent Technologies from $170.00 to $180.00 and gave the stock a “buy” rating in a research note on Tuesday. JPMorgan Chase & Co. increased their price target on Agilent Technologies from $165.00 to $180.00 and gave the stock an “overweight” rating in a research note on Tuesday. Finally, Bank of America raised their price objective on Agilent Technologies from $150.00 to $165.00 and gave the stock a “neutral” rating in a report on Tuesday. One analyst has rated the stock with a Strong Buy rating, eight have given a Buy rating and five have given a Hold rating to the company. According to data from MarketBeat.com, Agilent Technologies currently has an average rating of “Moderate Buy” and a consensus target price of $161.08.

Agilent Technologies Stock Up 2.4%

Shares of A opened at $157.25 on Wednesday. Agilent Technologies, Inc. has a fifty-two week low of $96.43 and a fifty-two week high of $160.27. The company’s fifty day moving average is $140.80 and its two-hundred day moving average is $126.03. The firm has a market cap of $44.58 billion, a PE ratio of 36.91, a price-to-earnings-growth ratio of 4.67 and a beta of 1.29. The company has a quick ratio of 1.71, a current ratio of 2.25 and a debt-to-equity ratio of 0.53.

Agilent Technologies (NYSE:A) last issued its earnings results on Monday, November 24th. The medical research company reported $1.59 earnings per share for the quarter, topping the consensus estimate of $1.58 by $0.01. Agilent Technologies had a return on equity of 25.51% and a net margin of 17.97%.The business had revenue of $1.86 billion for the quarter, compared to analyst estimates of $1.83 billion. During the same period last year, the company posted $1.46 EPS. The business’s quarterly revenue was up 9.4% on a year-over-year basis. Agilent Technologies has set its Q1 2026 guidance at 1.350-1.380 EPS. FY 2026 guidance at 5.860-6.000 EPS. Analysts forecast that Agilent Technologies, Inc. will post 5.58 earnings per share for the current year.

Agilent Technologies Increases Dividend

The company also recently announced a quarterly dividend, which will be paid on Wednesday, January 28th. Stockholders of record on Tuesday, January 6th will be issued a dividend of $0.255 per share. This represents a $1.02 dividend on an annualized basis and a dividend yield of 0.6%. The ex-dividend date is Tuesday, January 6th. This is an increase from Agilent Technologies’s previous quarterly dividend of $0.25. Agilent Technologies’s dividend payout ratio (DPR) is presently 23.94%.

Insider Activity

In related news, CEO Padraig Mcdonnell sold 911 shares of the stock in a transaction that occurred on Tuesday, November 18th. The shares were sold at an average price of $143.24, for a total transaction of $130,491.64. Following the completion of the sale, the chief executive officer owned 32,058 shares of the company’s stock, valued at approximately $4,591,987.92. This represents a 2.76% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Insiders own 0.26% of the company’s stock.

Agilent Technologies Company Profile

Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies.